These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15243539)

  • 1. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections.
    Cohen PR; Grossman ME
    J Am Acad Dermatol; 2004 Jul; 51(1):132-5. PubMed ID: 15243539
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of methicillin-resistant Staphylococcus aureus (MRSA) skin infections and MRSA colonization.
    Terushkin V; Brownell I
    J Drugs Dermatol; 2008 Jun; 7(6):597-601. PubMed ID: 18561595
    [No Abstract]   [Full Text] [Related]  

  • 3. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection.
    Moellering RC
    Clin Infect Dis; 2008 Apr; 46(7):1032-7. PubMed ID: 18444820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.
    Marcinak JF; Frank AL
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):91-100. PubMed ID: 16441212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Chambers HF
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S368-77. PubMed ID: 18462092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caution when reconsidering empiric antimicrobial therapy for methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.
    da Silva LV; Zavascki AP; de Souza MV; Marcadenti A
    Am J Surg; 2008 Oct; 196(4):618-9. PubMed ID: 18809069
    [No Abstract]   [Full Text] [Related]  

  • 7. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Whitman TJ
    Dis Mon; 2008 Dec; 54(12):780-6. PubMed ID: 18996280
    [No Abstract]   [Full Text] [Related]  

  • 8. Community-acquired methicillin-resistant Staphylococcus aureus infections in children.
    Kaplan SL
    Semin Pediatr Infect Dis; 2006 Jul; 17(3):113-9. PubMed ID: 16934705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: report of a local outbreak and implications for emergency department care.
    Fleming SW; Brown LH; Tice SE
    J Am Acad Nurse Pract; 2006 Jun; 18(6):297-300. PubMed ID: 16719849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of community-acquired methicillin-resistant Staphylococcus aureus infections.
    Fergie J; Purcell K
    Pediatr Infect Dis J; 2008 Jan; 27(1):67-8. PubMed ID: 18162942
    [No Abstract]   [Full Text] [Related]  

  • 11. The skin in the gym: a comprehensive review of the cutaneous manifestations of community-acquired methicillin-resistant Staphylococcus aureus infection in athletes.
    Cohen PR
    Clin Dermatol; 2008; 26(1):16-26. PubMed ID: 18280900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High recurrence rate of CA-MRSA skin and soft tissue infections.
    Skiest DJ; Cooper TW
    Arch Intern Med; 2007 Dec; 167(22):2527author reply 2527. PubMed ID: 18071179
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methicillin-resistant Staphylococcus aureus: an evolving clinical challenge.
    Karchmer AW; Bayer AS
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S342-3. PubMed ID: 18462088
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.
    Pallin DJ; Egan DJ; Pelletier AJ; Espinola JA; Hooper DC; Camargo CA
    Ann Emerg Med; 2008 Mar; 51(3):291-8. PubMed ID: 18222564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthy children with invasive community-acquired methicillin-resistant Staphylococcus aureus infections.
    Stankovic C; Mahajan PV
    Pediatr Emerg Care; 2006 May; 22(5):361-3. PubMed ID: 16714967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
    Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC
    J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
    Arnold FW; Wojda B
    J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community acquired methicillin-resistant Staphylococcus aureus hand infections: case reports and clinical implications.
    Karanas YL; Bogdan MA; Chang J
    J Hand Surg Am; 2000 Jul; 25(4):760-3. PubMed ID: 10913220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus.
    Gorwitz RJ
    Clin Infect Dis; 2007 Mar; 44(6):785-7. PubMed ID: 17304448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.